Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat Adults And Adolescents With Generalised Myasthenia Gravis

뉴스 본문을 불러오고 있어요.

Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat Adults And Adolescents With Generalised Myasthenia Gravis | 웨이프 WAPE

Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat Adults And Adolescents With Generalised Myasthenia Gravis

기사 요약

관련 종목

댓글 —